Literature DB >> 1558450

Pneumocystis carinii peritonitis. Antemortem confirmation of disseminated pneumocystosis by cytologic examination of body fluids.

W C Mathews1, S A Bozzette, S Harrity, W Meurer, T Viesca.   

Abstract

Histologic confirmation of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome has usually required organ biopsy when the diagnosis was made antemortem. Three cases of Pneumocystis peritonitis were studied in which confirmation of extrapulmonary dissemination was achieved by cytologic examination of ascitic fluid. Patients presented with characteristic choroidal lesions, transudative ascites, profound hypoalbuminemia, and hepatic dysfunction. Cytologic examination of ascitic fluid confirmed extrapulmonary dissemination of pneumocystis. All three patients died despite a minimum of 2 weeks of standard therapy. Cytologic examination of body fluids to confirm dissemination of Pneumocystis may obviate the need for organ biopsy. Disseminated pneumocystosis should be included in the differential diagnosis of ascites or peritonitis in a patient at risk for human immunodeficiency virus--associated opportunistic infections. The presence of transudative ascites may be characteristic of this syndrome.

Entities:  

Mesh:

Year:  1992        PMID: 1558450     DOI: 10.1001/archinte.152.4.867

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

Review 1.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Pneumocystis carinii infection of the small intestine.

Authors:  K Kinchen; T H Kinchen; T Inglesby
Journal:  J Natl Med Assoc       Date:  1998-10       Impact factor: 1.798

3.  Acute hepatic and renal failure caused by Pneumocystis carinii in patients with AIDS.

Authors:  R Boldorini; S Guzzetti; L Meroni; T Quirino; S Cristina; G Monga
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.